Yoshiaki Omura, MD, ScD

Omura, Yoshiaki 2208703_3685783 TP

1) Medical Researcher & Educator, Adjunct Professor, Family and Community Medicine, New York Medical College, Westchester, NY

2) President & Professor, International College of Acupuncture & Electro-Therapeutics, New York, NY

3) Former Director of Medical Research, Heart Disease Research Foundation, Brooklyn, NY

4) Formerly Visiting Research Professor, Department of Electrical Engineering, Manhattan College, Bronx, NY

Location: New York, New York, United States

Yoshiaki Omura, MD, ScD, Adjunct Professor at New York Medical College, has been recognized by Marquis Who’s Who Top Educators for dedication, achievements, and leadership in Basic and Clinical Medicine.

Dr. Omura has been an adjunct professor of New York Medical College in preventive, family, and community medicine, as well as a former professor of alternative medicine with the Ukrainian National Medical University, a member of the Alumni Council of the College of Physicians and Surgeons of Columbia University, and former director of medical research with the Heart Disease Research Foundation in Brooklyn, New York. He is a prolific international doctor and educator, known for his expertise in oncology, cardiology, pharmaco-electro physiology, neuroscience, acupuncture, forensic medicine, and a variety of other medical techniques, as well as the invention of the Bi-Digital O-Ring Test (BDORT, which received U.S. Patent in 1993) and numerous patents in the U.S. and Japan. Dr. Omura has been healing the sick since 1954, and was honored with the Albert Nelson Marquis Lifetime Achievement Award, as well as inclusion in the pages of Who’s Who in America, Who’s Who in American Education, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, and Who’s Who in the World.

Born in Tomari, Japan to Tsunejiro and Minako Omura, Dr. Omura attended Electrical Engineering School of Nihon University and received a BSc in Applied Physics in 1957 from Waseda University. He earned an MD from Yokohama City University and served internships at Tokyo University Hospital and Norwalk Hospital, ultimately arriving at Columbia University as a Research Fellow of Thoracic Surgery in 1960. After that, he became a Visiting Research Professor of the Department of Electrical Engineering in Manhattan College from 1961 to 1999. One evening a week, he taught one of the first courses on Biomedical Electronics in USA and did medical electronics research in their electronics laboratory.

From there, Dr. Omura studied Graduate Experimental Physics at Pupin Laboratory of Columbia University. There, he discovered the basic principle of highly sensitive electro-magnetic field (EMF) resonance phenomena between two identical molecules with identical weight, which became the main principle of BDORT. Using this EMF resonance phenomena, he discovered the simple method of detecting any molecules (including any cancers) non-invasively without even touching the body. He was able to detect any molecules at any part of the body non-invasively without biopsy or blood test for which a U.S. Patent was given.

Then in 1965, he received a ScD (Doctor of Science) from the research on Pharmaco-Electro Physiology of Single Cardiac Cells In Vivo & In Vitro from Columbia University. At the time, he was a resident physician in oncological surgery at the Francis Delafield Hospital, which was the Cancer Institute of Columbia University. From 1966 to 1972, he became an assistant professor of pharmacology at New York Medical College. He then became the Visiting Professor of the University of Paris during the summer for four years. Dr. Omura was a distinguished foreign scientist with the French National Institute of Health and Medical Research, and has spearheaded international groups to address cancer, heart disease, forensic research, drug detoxification, and other medical efforts.

In addition to working groups, Dr. Omura is a prolific contributor to medical literature, and still serves in an editorial capacity with the American Journal of Traditional Chinese Medicine, the Scandinavian Journal of Acupuncture and Electrotherapy, and the Acupuncture & Electro-Therapeutics Research International Journal, which he founded and where he still serves as editor-in-chief. He has received numerous awards, notably the 1990 World First Qi Gong Scientist of the Year Award from the International Congress of Chinese Medicine and Qi Gong, and has been funded by the National Institutes of Health, the John Polacek Foundation, and the American Cancer Society, among numerous accolades. Dr. Omura is the proud father of Alexander Kenji, Vivienne Midori, and Richard Itsuma. He became a naturalized American citizen in 1979.

Since his wife died from serious cancer in spite of the treatment by the hospital of a major university, Dr. Omura has focused his research on both non-invasive, early, diagnostic method of various cancers and safe, effective, individualized treatment of cancers. As a result, he developed accurate organ representation areas of different parts of the body such as face including eyebrows, pupils, nose, upper and lower lips, upper surface and underside of the tongue, hands, and feet. From there, he discovered when there is any malignancy of any organ, corresponding organ representation area will have either visible or invisible abnormalities. Some of them appear as visible, deep crease and some appear as dark pigmentation of the corresponding organs. He was able to map some of these frequently visible abnormalities in organ representation map of face. Also, when there is a visible abnormality, there is always invisible, biological abnormality that exists, which can be non-invasively and rapidly detected. Therefore, in some patients, just by evaluating any unique, physical abnormalities rapid screening can be performed. In the case of malignancy being suspected, by using a cancer microscope slide by detecting strong EMF resonance, cancer can be confirmed non-invasively and rapidly. From the same abnormal location, we can detect invisible, cancer-related, biochemical abnormalities. He developed non-invasive, quick, screening method using new, accurate organ representation area maps of different organs on face particularly lips, eyebrows, nose, upper and lower lips. The lips do not always show visible changes but often show invisible changes including strong (-) BDORT value of (-)7 or higher (-) value and cancer corresponding biochemical changes.

Dr. Omura developed a second method of “1-Page of Mouth, Hand, Foot Writing Form” since early 2000. Every year he has refined the method. Now with this, when the patient fills out the form, which takes anywhere between 5-10 minutes, he is able to detect any malignancy at any part of the body non-invasively and rapidly.

The third method he discovered is the detection of cancer from rapidly changing QRS-Complex as well as rising part of the T-wave of ECGs which was discovered by him in 2013. It was well known that Human Papilloma Virus Type 16 (HPV-16) and Type 18 have major cause of malignancy of the uterus, ovaries, and breast(s) but his research indicated that in most of cancer he found HPV-Type 16 using EMF resonance phenomena. HPV-16 alone does not seem to create cancer and he was looking for additional factors, specifically associated with the genesis of cancer. Finally, he found as one of the possible factors needed to create the cancer single-cell, intracellular parasite, Toxoplasma Gondii infection co-exists together with HPV-16 and when the value of both infections is both very high, he found a very high incidence of development of cancer. He realized that all the cancer patients he examined have both increased infections co-existing and also that one of the most important treatments for cancer should also include removing these infections. He also considered these infections as highly infectious. Therefore, he considered many of the cancers as potentially infectious to the people who live at a very close vicinity together.

In 2017, he developed a fourth supplemental method of detecting malignancies from Thymus gland representation areas on manubrium. At the same time, he also developed the new, simple, non-invasive method of individualized treatment of cancer using optimal dose of Vitamin D3.

In 2016, Dr. Omura discovered seven unique, beneficial effects of optimal dose of Vitamin D3, which became the most important part of his safe, effective, individualized cancer treatment which has been saving many hopeless cancer patients who are treated by many well-known university hospitals but the treatment is no longer helping. Using optimal dose of Vitamin D3, some of these seven factors include 1) very safe, effective, anti-cancer effects without damaging any normal cells, 2) it eliminates viruses, bacteria, fungi, single-cell parasites in the urine with as well as toxic substances including metals like mercury red and aluminum. Therefore, the individualized use of optimal dose of Vitamin D3 is the most safe, effective and economical cancer treatment. He has been able to save or significantly prolong many hopeless cancer patients abandoned by major hospitals.

Furthermore, Dr. Omura discovered four different methods of non-invasive, rapid, early detection of various cancers including detection of cancer from electrocardiograms and new individualized, safe, effective treatment of various cancers & their metastases using combined four different principles he discovered during the past 15 years: 1) individualized, optimal dose of Vitamin D3 using its 10 unique beneficial effects average of every 8 hours, 2) selective drug uptake enhancement method to pathological organ, 3) manual stimulation of Thymus gland representation areas on the back of the hand (which was discovered by him in 2017), 4) identification & removal of co-existing multiple cancer-promoting factors. Using this new approach, many lives of advanced, hopeless cancer patients have been saved. In Cardiology, he discovered one of the major causes of atrial fibrillation is due to infection of Lyme Disease due to Borrelia Burgdorferi Spirochete which can be detected through SA node area & P-wave of ECGs. His work on Oncology, Cardiology, & Forensic Medicine (he discovered the following two important new methods: 1) Rapid, Non-Invasive Method of Detecting Potential Mass Murderers by Non-Invasively Detecting Extremely Low Amount of Brain Acetylcholine 1ng or Less Compared with normal average amount of 2000~3000ng & successfully increasing to over 3000ng, and 2) New, Invisible “Lie Reflex” with Distinctive Biochemical Changes which Appears at Specific Part of the Face & lasts about 10~15 Seconds after Person is Finishing Lie Statement which can be Recorded with Photograph or Video) & it is probably the most reliable method of detecting lies now available; it is strongly attracting worldwide attention. As such, Dr. Omura frequently appears as a keynote speaker on his subjects of expertise.

In February 2017, he was a Keynote Speaker at European Parliament by invitation of Chairman of Anti-Cancer Committee of European Parliament. Using non-invasive BDORT and non-invasive, biochemical, unique changes in the pupil directly from the patient or photograph. He has been successfully able to screen potential mass murderers and potential mass killers by car accidents. In these patients, the pupil of the eye indicates a BDORT of (-)12, which is strongest (-) value of BDORT. Extremely reduced acetylcholine of less than 1ng using EMF resonance and markedly increased β-Amyloid (1-42), which increases in the presence of Alzheimer’s Disease. This work was presented as a Keynote Lecture at the Forensic Research & Technology Congress of 2016 and 2017.

For more:

Worldwide Humanitarian


Contact Dr. Omura

Leave a Reply